Recently, Zhou and colleagues [166] showed that systemic administration of Nrf-2-overexpressing hair follicle (HF)-MSCs (1 × 106 cells) had a more prominent therapeutic effect in colitic rats compared with naïve MSCs. The gene discussed is NFE2L2; the disease is hydrops fetalis.